If someone told you that asthma would help you win gold at the Olympics, would you believe them? Well according to a new study, athletes with asthma are more likely to win at the Winter Games than those without these breathing problems. Claire Maldarelli, Assistant Editor at Popular Science, explains the science behind the study.
The issue of asthma and inhalers has been divisive for a long time within the International Olympic Committee. Until recently many types of inhalers were banned. The rules and regulations on medications still change regularly.
Car culture in the U.S. spurred a parking boom since the early 1900s. As a result, cities are chock full of parking lots and garages. Cheddar explains why this happened and the often unseen damage it's doing to our urban centers.
Jill and Carlo talk about optimism on the pandemic and economy, a big demographic shift that will have implications for the midterms, Apple rolling out its new privacy tool, and the Oscars ratings.
Clive McCoy, director of tourism for the British Virgin Islands, joined Cheddar to discuss how the territory was relaxing restrictions for travel to resume back to the tropical getaway.
While much of the world remains hunkered down, the band Six60 has been playing to huge crowds in New Zealand, where social distancing isn’t required after the nation stamped out the coronavirus.
The charitable arm of San Francisco-based technology giant Cisco Systems has pledged to invest $100 million over the next decade to help reverse the impact of climate change.
The White House says the U.S. will begin sharing its entire stock of AstraZeneca COVID-19 vaccines with the world once it clears federal safety reviews.
Officials say the European Union is finalizing plans to allow tourists from the United States to travel to the 27-nation bloc this summer.
Jill is joined by Baker Machado this morning to talk about the CDC reinstating the J&J vaccine, a worsening Coronavirus crisis in India, but also, where things are looking a lot better.
Michigan has become the current national hotspot for COVID-19 infections and hospitalizations at a time when more than half the U.S. adult population has been vaccinated and other states have seen the virus diminish substantially.
A U.S. health panel says it’s time to resume use of Johnson & Johnson’s COVID-19 vaccine, despite a very rare risk of blood clots.
